株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

放射線療法・放射性医薬品・核医学の世界市場

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

発行 BCC Research 商品コード 851712
出版日 ページ情報 英文 232 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
放射線療法・放射性医薬品・核医学の世界市場 Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
出版日: 2019年05月17日 ページ情報: 英文 232 Pages
概要

世界の放射性医薬品・治療薬の市場は予測期間中9.2%のCAGR (年間複合成長率) で推移し、2018年の141億ドルから、2023年には220億ドルの規模に成長すると予測されています。

当レポートでは、世界の放射線療法・放射性医薬品・核医学の市場を調査し、市場の定義と概要、法規制上の枠組み、主要動向・市場成長への各種影響因子の分析、照射法・診断/治療区分・製造法・技術・用途・地域/主要国など各種区分別の動向と市場規模の推移と予測、産業構造、パイプライン動向、特許分析、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 放射性医薬品
  • 放射線療法
  • 放射線治療
  • 市場の潜在性
  • 地域的展望
  • 投資分析
  • 市場シェア分析
  • 市場の分類:概要
    • 放射線療法タイプ別
    • 放射性医薬品タイプ別
    • 製造法別
    • 技術別
    • 用途別
  • 地域概要
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第4章 市場力学

  • 動向
  • 成長推進因子
  • 成長抑制因子
  • 市場機会

第5章 市場分析・予測:タイプ別

  • 放射線療法
    • 外照射
    • 内照射
    • 全身照射
  • 放射性医薬品
    • 診断
    • 治療

第6章 市場分析・予測:製造法別

  • 粒子加速器 (サイクロトロン)
  • 原子炉
  • ラジオアイソトープジェネレーター

第7章 市場分析・予測:技術別

  • 外照射:技術別
    • 粒子線治療/陽子線治療
    • SRS・分割定位放射線治療
    • IGRT
    • IMRT
    • トモセラピー
    • 3D-CRT
    • VMAT
  • 内照射:技術別
    • PDR小線源治療 (ブラキセラピー)
    • LDR小線源治療
    • HDR小線源治療
  • 全身照射:技術別
    • α・β放射体の比較

第8章 市場分析・予測:用途別

  • 外照射療法
    • 治療計画
    • 線量と治療
    • LINACS
  • 内照射療法
    • 用途
  • 全身照射療法
    • 用途

第9章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第10章 産業構造

  • 原材料の調達
  • 製造/開発プロセス
  • 流通業者
  • エンドユーザー

第11章 新たな開発・現況

  • パイプライン製品
  • 現在の市場シナリオ

第12章 特許分析

  • 米国
  • 欧州
  • 日本

第13章 競合環境

  • 製品の上市
  • 提携・合意・協力
  • M&A

第14章 企業プロファイル

図表

List of Tables

  • Summary Table: Global Radiopharmaceutical and Therapeutics Market, by Region, Through 2023
    • Table 1: Milestones in the Discovery of Radioactivity and Nuclear Medicine
    • Table 2: Prevalence of Different Cancers in Top Countries, 2016
    • Table 3: Deaths from Cancers in Top Countries, by Cancer Type, 2016
    • Table 4: Summary of Regulatory Affairs Across Countries
    • Table 5: Investments in Radiopharmaceutical and Therapeutics Market
    • Table 6: Global Radiopharmaceutical Market Share Analysis, by Company, 2017
    • Table 7: Global Therapeutics Market Share Analysis, by Company, 2017
    • Table 8: Global Geriatric Population (60 Years+), by Region, 2015, 2030 and 2050
    • Table 9: Global Prevalence of Cancer, by Type, 2016
    • Table 10: Major Types of Cancer Prevalence, by Region, 2015 and 2016
    • Table 11: Need for Linear Accelerators and Radiotherapy Departments, 2015 and 2035
    • Table 12: Global Radiotherapy Market, by Type, Through 2023
    • Table 13: Global Cancer Prevalence and Cancer Mortality Rate, 2018 and 2030
    • Table 14: Global Cancer Deaths, by Type, 2016
    • Table 15: Global External Beam Radiotherapy Market, by Type, Through 2023
    • Table 16: Global External Beam Radiotherapy Market, by Region, Through 2023
    • Table 17: Global Electron-Emitting High-Energy Linear Accelerators Market, by Region, Through 2023
    • Table 18: Global Compact Radiotherapy System Market, by Type, Through 2023
    • Table 19: Global Compact Radiotherapy System Market, by Region, Through 2023
    • Table 20: Global CyberKnife Market, by Region, Through 2023
    • Table 21: Global Prevalence of Dementia, 2015, 2030 and 2050
    • Table 22: Global Distribution of People Living with Dementia, by Region, 2015, 2030 and 2050
    • Table 23: Global Gamma Knife Market, by Region, Through 2023
    • Table 24: Global Tomotherapy Market, by Region, Through 2023
    • Table 25: Global Proton Therapy System Market, by Type, Through 2023
    • Table 26: Global Proton Therapy System Market, by Region, Through 2023
    • Table 27: Global Cyclotron Market, by Region, Through 2023
    • Table 28: Global Synchrotron Market, by Region, Through 2023
    • Table 29: Global Internal Radiotherapy/Brachytherapy Market, by Type, Through 2023
    • Table 30: Global Internal Radiotherapy/Brachytherapy Market, by Region, Through 2023
    • Table 31: Global Brachytherapy Seed Market, by Region, Through 2023
    • Table 32: Global Applicator and Afterloader Market, by Region, Through 2023
    • Table 33: Global External Brachytherapy Market, by Region, Through 2023
    • Table 34: Global Systemic Radiotherapy Market, by Region, Through 2023
    • Table 35: Global Systemic Radiotherapy Market, by Type, Through 2023
    • Table 36: Global Radiopharmaceutical Market, by Type, Through 2023
    • Table 37: Global Deaths Caused by Chronic Diseases, by Type, 2015
    • Table 38: Pharmaceutical Spending Share, by Country, 2016
    • Table 39: Global Diagnostic Radiopharmaceutical Market, by Type, Through 2023
    • Table 40: Global Diagnostic Radiopharmaceutical Market, by Region, Through 2023
    • Table 41: Global PET Radiopharmaceutical Market, by Type of Radionuclide, Through 2023
    • Table 42: Global SPECT Radiopharmaceutical Market, by Type of Radionuclide, Through 2023
    • Table 43: Global Other Diagnostic Radiopharmaceuticals Market, by Type of Radionuclide, Through 2023
    • Table 44: Global Therapeutic Radiopharmaceutical Market, by Type of Therapeutic, Through 2023
    • Table 45: Global Therapeutic Radiopharmaceutical Market, by Region, Through 2023
    • Table 46: Global Alpha Emitter Market, by Type of Radionuclide, Through 2023
    • Table 47: Global Beta Emitters Market, by Type of Radionuclide, Through 2023
    • Table 48: Global Brachytherapy Seeds Market, by Type of Radionuclide, Through 2023
    • Table 49: Global Radiopharmaceuticals Market, by Production Method, Through 2023
    • Table 50: Comparison of External Beam Radiation Therapy (EBRT) and Brachytherapy
    • Table 51: Comparison of Technologies in Radiotherapy
    • Table 52: Global External Radiotherapy Market, by Technology, Through 2023
    • Table 53: Global Particle Therapy Market, by Region, Through 2023
    • Table 54: Global Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy Market, by Region, Through 2023
    • Table 55: Global Image-Guided Radiotherapy Market, by Region, Through 2023
    • Table 56: Global Intensity-Modulated Radiotherapy Market, by Region, Through 2023
    • Table 57: Comparison of Tomotherapy and Conventional Radiotherapy
    • Table 58: Global Tomotherapy Market, by Region, Through 2023
    • Table 59: Global Three-Dimensional Conformal Radiotherapy Market, by Region, Through 2023
    • Table 60: Global Volumetric Modulated ARC Therapy Market, by Region, Through 2023
    • Table 61: Advantages and Disadvantages of Brachytherapy
    • Table 62: Various Types of Brachytherapy Implants
    • Table 63: Brachytherapy Treatment Duration
    • Table 64: Brachytherapy Treatment Dose Rate
    • Table 65: Brachytherapy Treatment Source Loading
    • Table 66: Comparison of Low-Dose and High-Dose Radiation Therapy
    • Table 67: Benefits and Drawbacks of High-Dose-Rate (HDR) Brachytherapy
    • Table 68: Comparison of Alpha and Beta Particles
    • Table 69: Benefits and Drawbacks of Radiopharmaceuticals
    • Table 70: Mechanisms of Radiopharmaceutical Localization
    • Table 71: Global Radiotherapy Market, by Application, Through 2023
    • Table 72: New Cancer Cases and Estimated Deaths, 2016
    • Table 73: Global Number of Cancer Cases, 2012 and 2030
    • Table 74: Estimates for Lung Cancer in the United States for 2018
    • Table 75: Global External Beam Radiotherapy Market, by Application, Through 2023
    • Table 76: Global Internal Beam Radiotherapy Market, by Application, Through 2023
    • Table 77: Commonly Used Radionuclides (Radiation Sources) Half-Life for Brachytherapy
    • Table 78: Global Systemic Radiotherapy Market, by Application, Through 2023
    • Table 79: Global Radiopharmaceutical and Therapeutics Market, by Region, Through 2023
    • Table 80: North American Radiopharmaceutical and Therapeutics Market, by Country, Through 2023
    • Table 81: New Cancer Cases and Estimated Deaths, 2016
    • Table 82: Aging U.S. Population, 2000-2050
    • Table 83: North American Radiotherapy Market, by Type, Through 2023
    • Table 84: New HIV Diagnoses in the United States, by Age Group, 2016
    • Table 85: Healthcare Expenditures, by Source, Canada, 2015 and 2040
    • Table 86: North American Radiopharmaceutical Market, by Type, Through 2023
    • Table 87: Rising Aging Population (65 Years and Older) in Canada, 1996-2016
    • Table 88: European Radiopharmaceutical and Therapeutics Market, by Country, Through 2023
    • Table 89: European Radiotherapy Market, by Type, Through 2023
    • Table 90: Estimated Number of People Living with Cancer in U.K., by Country, 2015 and 2020
    • Table 91: European Radiopharmaceutical Market, by Type, Through 2023
    • Table 92: Health Spending and Financing, 2005-2015
    • Table 93: Rising Geriatric Population in Germany, 2000-2030
    • Table 94: Rising Number of Cancer Cases in Spain, 2012 and 2015
    • Table 95: Estimate of Elderly People with Dementia (Aged 60+) in Denmark, 2017-2040
    • Table 96: Asia-Pacific Radiopharmaceutical and Therapeutics Market, by Country, Through 2023
    • Table 97: Asia-Pacific Radiotherapy Market, by Type, Through 2023
    • Table 98: Number of People with Cancer in China, 2010-2016
    • Table 99: R&D Spending in India, by Top Pharmaceutical Companies
    • Table 100: Japanese Pharmaceutical Industry, 2010-2015
    • Table 101: Estimated Most Commonly Diagnosed Cancers, by Type, 2018
    • Table 102: Commonly Diagnosed Cancer Cases in Australia, by Gender and Cancer Type, 2017
    • Table 103: Asia-Pacific Radiopharmaceutical Market, by Type, Through 2023
    • Table 104: Rest of World Radiopharmaceutical and Therapeutics Market, by Region, Through 2023
    • Table 105: Number of Cyclotrons Operating in Brazil, 2010-2015
    • Table 106: Rest of World Radiotherapy Market, by Type, Through 2023
    • Table 107: Share of Leading Causes of Deaths Related to Cancer in the UAE, by Cancer Type, 2015
    • Table 108: Rest of World Radiopharmaceutical Market, by Type, Through 2023
    • Table 109: Global Suppliers for the Radiopharmaceutical and Therapeutics Market
    • Table 110: Selected Manufacturers of Instruments in Radiopharmaceutical and Therapeutics Market
    • Table 111: Number of Cancer Deaths in Top Countries, by Type of Cancer, 2016
    • Table 112: Radiopharmaceuticals in Clinical Trials, 2019
    • Table 113: U.S. Patents on Radiopharmaceuticals and Therapeuticss, 2016-2018
    • Table 114: European Patents on Radiopharmaceuticals and Therapeutics, 2016-2018
    • Table 115: Japanese Patents and Patent Applications on Radiopharmaceuticals and Therapeutics, 2016-2018
    • Table 116: Product Launches of Radiopharmaceuticals and Therapeutics
    • Table 117: Collaborations, Agreements, and Partnerships in Radiopharmaceuticals and Therapeutics
    • Table 118: Mergers and Acquisitions in Radiopharmaceuticals and Therapeutics
    • Table 119: Accuray: Product Portfolio
    • Table 120: Accuray: Recent Developments, 2016-2018
    • Table 121: Actinium Pharmaceuticals Inc.: Product Portfolio
    • Table 122: Actinium Pharmaceuticals Inc.: Recent Developments, 2016-2018
    • Table 123: Advanced Accelerator Applications SA: Product Portfolio
    • Table 124: Advanced Accelerator Applications SA: Recent Developments, 2016-2018
    • Table 125: Advanced Medical Isotope Corp.: Product Portfolio
    • Table 126: Advanced Medical Isotope Corp.: Recent Developments, 2016-2018
    • Table 127: Alliance Medical Group: Product Portfolio
    • Table 128: Alliance Medical Group: Recent Developments, 2016-2018
    • Table 129: Australian Nuclear Science and Technology Organisation: Product Portfolio
    • Table 130: Aytu BioScience Inc.: Product Portfolio
    • Table 131: Bayer Pharma AG: Product Portfolio
    • Table 132: Blue Earth Diagnostics Ltd.: Product Portfolio
    • Table 133: Blue Earth Diagnostics Ltd.: Recent Development, 2016-2018
    • Table 134: Board of Radiation and Isotope Technology: Product Portfolio
    • Table 135: Bracco Diagnostics Inc.: Product Portfolio
    • Table 136: Bracco Diagnostics Inc.: Recent Development, 2016-2018
    • Table 137: BTG International Ltd.: Product Portfolio
    • Table 138: BTG International Ltd.: Recent Developments, 2016-2018
    • Table 139: C. R. Bard Inc.: Product Portfolio
    • Table 140: C. R. Bard Inc.: Recent Developments, 2016-2018
    • Table 141: Cardinal Health Inc.: Product Portfolio
    • Table 142: Cardinal Health Inc.: Recent Developments, 2016-2018
    • Table 143: Clarity Pharmaceuticals: Product Portfolio
    • Table 144: Clarity Pharmaceuticals: Recent Developments, 2016-2018
    • Table 145: Coqui RadioPharmaceuticals: Product Portfolio
    • Table 146: Eckert & Ziegler BEBIG: Product Portfolio
    • Table 147: Eckert & Ziegler BEBIG: Recent Developments, 2016-2018
    • Table 148: Elekta: Product Portfolio
    • Table 149: Elekta: Recent Developments, 2016-2018
    • Table 150: Eli Lilly and Co.: Product Portfolio
    • Table 151: Eli Lilly and Co.: Recent Developments, 2016-2018
    • Table 152: Fujifilm RI Pharma Co. Ltd.: Product Portfolio
    • Table 153: Fujifilm RI Pharma Co. Ltd.: Recent Developments, 2016-2018
    • Table 154: GE Healthcare: Product Portfolio
    • Table 155: GE Healthcare: Recent Developments, 2016-2018
    • Table 156: IBA Molecular: Product Portfolio
    • Table 157: IBA Molecular: Recent Developments, 2016-2018
    • Table 158: IsoRay Medical Inc.: Product Portfolio
    • Table 159: Iso-Tex Diagnostics Inc.: Product Portfolio
    • Table 160: Jubilant DraxImage Inc.: Product Portfolio
    • Table 161: Lantheus Medical Imaging Inc.: Product Portfolio
    • Table 162: NanoThea: Product Portfolio
    • Table 163: National Centre for Nuclear Research Radioisotope Centre POLATOM: Product Portfolio
    • Table 164: National Institute for Radioelements: Product Portfolio
    • Table 165: Navidea Biopharmaceuticals Inc.: Product Portfolio
    • Table 166: Navidea Biopharmaceuticals Inc.: Recent Developments, 2016-2018
    • Table 167: Nordion Inc.: Product Portfolio
    • Table 168: NTP Radioisotopes SOC Ltd.: Product Portfolio
    • Table 169: Pharmalucence Inc.: Product Portfolio
    • Table 170: PMB ALCEN: Product Portfolio
    • Table 171: Siemens Healthcare: Product Portfolio
    • Table 172: Spectrum Pharmaceuticals Inc.: Product Portfolio
    • Table 173: Triad Isotopes Inc.: Product Portfolio
    • Table 174: Varian Medical Systems: Product Portfolio
    • Table 175: Varian Medical Systems: Recent Developments, 2016-2018
    • Table 176: Zevacor: Product Portfolio

List of Figures

  • Summary Figure: Global Radiopharmaceutical and Therapeutics Market, by Region, 2017-2023
    • Figure 1: Types of Radiation
    • Figure 2: Prevalence of Different Types of Cancers in Top Countries, 2016
    • Figure 3: Deaths from Cancers in Top Countries, by Cancer Type, 2016
    • Figure 4: Global Radiopharmaceutical Market Share Analysis, by Company, 2017
    • Figure 5: Global Therapeutics Market Share Analysis, by Company, 2017
    • Figure 6: Respiratory Gating Procedure
    • Figure 7: Global Trends in Rising Aged Population, 2014-2022
    • Figure 8: Heart Disease: Share of Mortalities in America, by Disease Type, 2017
    • Figure 9: Prevalence of Cancer Across Global Regions, 2015 and 2016
    • Figure 10: Global Aging Population, 1990-2050
    • Figure 11: Factors Related to Aging and the Promotion of Cancer
    • Figure 12: Global Prevalence of Cancer, by Type, 2016
    • Figure 13: Rising Trends in Healthcare Spending, by Institution, 2015-2040
    • Figure 14: Global Cancer Prevalence and Cancer Mortality Rate, 2018 and 2030
    • Figure 15: Global Cancer Deaths, by Type, 2016
    • Figure 16: Types of Beams Used in Radiation Therapy
    • Figure 17: Common Types of Compact Advance Radiotherapy Systems
    • Figure 18: Global Prevalence of Dementia, 2015, 2030 and 2050
    • Figure 19: Global Distribution of People Living with Dementia, by Region, 2015, 2030 and 2050
    • Figure 20: Global Deaths Caused by Chronic Diseases, by Type, 2015
    • Figure 21: Pharmaceutical Spending Share, by Country, 2016
    • Figure 22: Different Types of Diagnostic Radiopharmaceuticals
    • Figure 23: Types of Therapeutic Radiopharmaceuticals
    • Figure 24: Different Production Techniques of Radiopharmaceuticals
    • Figure 25: Block Diagram of Particle Accelerators
    • Figure 26: Block Diagram of External Radiotherapy Technologies
    • Figure 27: Block Diagram of Particle Therapy/Proton Beam Therapy
    • Figure 28: Block Diagram of Stereotactic Radiosurgery
    • Figure 29: Procedure of Image-Guided Radiotherapy (IGRT)
    • Figure 30: Block Diagram of Three-Dimensional Conformal Radiation Therapy (3D-CRT)
    • Figure 31: Procedure of LDR Prostate Brachytherapy
    • Figure 32: Types of External Radiation Therapy
    • Figure 33: Global Number of Cancer Cases, 2012 and 2030
    • Figure 34: Estimated New Cases of Leukemia, Lymphoma, and Myeloma, 2018
    • Figure 35: New HIV Diagnoses in the United States, by Age Group, 2016
    • Figure 36: Canadian Healthcare Expenditures, by Source, 2015 and 2040
    • Figure 37: Rising Aging Population (65 Years and Older) in Canada, 1996-2016
    • Figure 38: Health Spending and Financing, 2005-2015
    • Figure 39: Rising Geriatric Population in Germany, 2000-2030
    • Figure 40: Rising Number of Cancer Cases in Spain, 2012 and 2015
    • Figure 41: Number of People with Cancer in China, 2010-2016
    • Figure 42: R&D Spending in India, by Top Pharmaceutical Companies, 2017
    • Figure 43: Japanese Pharmaceutical Industry, 2010-2015
    • Figure 44: Estimated Most Commonly Diagnosed Cancers, by Type, 2018
    • Figure 45: Industry Structure of Instruments and Medicines in the Radiopharmaceutical and Therapeutics Market
目次
Product Code: HLC176C

Report Highlights:

The global radiopharmaceutical and therapeutics market should reach $22.0 billion by 2023 from $14.1 billion in 2018 at a compound annual growth rate (CAGR) of 9.2% for the period of 2018 to 2023.

North American radiopharmaceutical and therapeutics market is expected to grow from $5.4 billion in 2018 to $8.4 billion in 2023 at a CAGR of 9.1% for the period of 2018 to 2023.

Asia-Pacific radiopharmaceutical and therapeutics market is expected to grow from $3.4 billion in 2018 to $5.4 billion in 2023 at a CAGR of 9.8% for the period of 2018 to 2023.

Report Scope:

The scope of this report is broad and covers type, production method, technology and applications of radiopharmaceuticals and therapeutics. By type, the market has been segmented into radiotherapy and radiopharmaceuticals. Revenue forecasts from 2017 to 2023 are provided for each segment and regional market, with estimated values derived from manufacturers' total revenues.

The report also includes a discussion of the major players in each region in the radiopharmaceutical and therapeutics market. Further, it explains the major drivers and regional dynamics of the global radiopharmaceutical and therapeutics market and current trends within the industry.

The report concludes with a special focus on the vendor landscape and detailed profiles of the major vendors in this market.

Report Includes:

  • 94 data tables and 83 additional tables
  • An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
  • Examination of present and future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
  • Detailed description of positron emission tomography (PET) and single photon emission computed tomography (SPECT) and discussion of their applications
  • Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
  • Coverage of new products launches and product enhancement in the industry
  • Comprehensive company profiles of major players, including Accuray Inc., Bayer Pharma AG, C. R. Bard Inc., Eli Lilly and Company, Navidea Biopharmaceuticals Inc., Siemens Healthcare, and Triad Isotopes Inc.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Executive Summary

Chapter 3: Market Overview

  • Introduction: Radiopharmaceuticals
    • Uses of Radiopharmaceuticals
  • Evolution and Transition: Radiopharmaceuticals
  • Introduction: Radiotherapy
    • Ionizing Radiation
    • Non-ionizing Radiation
  • Evolution and Transition: Radiation Therapy
    • The Discovery Period: 1890s
    • Kilovoltage Era: 1900 to 1940
    • Megavoltage Era: 1946 to 1996
    • Computer-Assisted Era: 1996 to the Present
  • Market Potential
  • Regulatory Outlook
    • United States
    • Canada
    • Australia
    • India
    • European Union
  • Investment Analysis
  • Market Share Analysis
  • Segmentation Overview
    • Segmentation by Type: Radiotherapy
    • Segmentation by Type: Radiopharmaceuticals
    • Segmentation by Production Method
    • Segmentation by Technology
    • Radiopharmaceutical and Therapeutics Market, by Application
  • Geographic Overview
    • North America
    • Europe
    • Asia-Pacific
    • RoW

Chapter 4: Market Dynamics

  • Trends
    • Respiratory Gating
    • Proton Therapy
    • Carbon Ions
    • Magnetic Resonance-Driven Linear Accelerator
  • Drivers
    • Increasing Aging Population
    • Increasing Incidence of Life-Threatening Diseases
    • Increasing Incidences of Cancer
    • High Incidence of Cancer in Aging Population
    • Growing Healthcare Spending in Emerging Regions
    • Advancements in Technology
    • Growing Focus on Early Diagnosis and Treatment
    • Launch of New Radiopharmaceuticals and Widening Applications
    • Increasing Number of Cyclotrons
    • Increasing Amount of Nuclear Imaging Equipment
    • High Efficiency of Radiotherapy
    • Palliative Radiation Therapy
    • Government Funding
    • Reimbursement Boosting Market Growth
  • Restraints and Challenges
    • Limited Global Supply of Medical Isotopes
    • Reimbursement Policies
    • Healthcare Reforms and Budgetary Constraints in Developed Countries
    • Regulatory Issues
    • Expensive Equipment
    • Lack of Trained Professionals
    • Limited Effectiveness against Metastatic Cancer
    • Side Effects of Radiation Therapy
    • Therapeutic Bottlenecks
  • Opportunities
    • Developing Countries
    • Personalized Treatment
    • Replacement of Old Equipment

Chapter 5: Global Radiopharmaceutical and Therapeutics Market by Type

  • Radiotherapy
    • External Beam Radiation Therapy
    • Internal Radiation Therapy
    • Systemic Radiotherapy
  • Radiopharmaceuticals
    • Diagnostics
    • Therapeutics

Chapter 6: Global Radiopharmaceutical and Therapeutics Market by Production Method

  • Particle Accelerators (Cyclotrons)
    • Working of Particle Accelerators
  • Nuclear Reactors
  • Radionuclide Generators
    • Production of Radioisotopes through Radionuclides

Chapter 7: Global Radiopharmaceutical and Therapeutics Market by Technology

  • External Radiotherapy Market by Technology
    • Particle Therapy/Proton Beam Therapy
    • Stereotactic Radiosurgery (SRS) and Fractionated Stereotactic Radiation Therapy
    • Image-Guided Radiation Therapy (IGRT)
    • Intensity-Modulated Radiation Therapy (IMRT)
    • Tomotherapy
    • Three-Dimensional Conformal Radiation Therapy (3D-CRT)
    • Volumetric Modulated Arc Therapy (VMAT)
  • Internal Radiotherapy by Technology
    • Pulsed-Dose-Rate (PDR) Brachytherapy
    • Low-Dose-Rate Brachytherapy
    • High-Dose-Rate (HDR) Brachytherapy
  • Systemic Radiotherapy by Technology
    • Comparison between Alpha and Beta Emitters

Chapter 8: Global Radiopharmaceutical and Therapeutics Market by Application

  • External Beam Radiation Therapy
    • Treatment Planning for External Beam Radiation
    • Dosing and Treatment with External Beam Radiation
    • Electron-Emitting High-Energy Linear Accelerators (LINACS)
  • Internal Radiation Therapy
    • Applications of Internal Beam Radiation Therapy
  • Systemic Radiation Therapy
    • Applications of Systemic Radiation Therapy

Chapter 9: Geographic Analysis

  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • France
    • Germany
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Rest of World (ROW)
    • Latin America
    • Middle East and Africa

Chapter 10: Industry Structure

  • Raw Material Procurement
    • Quality
    • Terms and Conditions
    • Cost-Effective Components
  • Manufacturing/Development Process
  • Distributors
  • End Users

Chapter 11: New Development and Current Situation

  • Pipeline Products
  • Current Market Scenario
    • Current Developments in Radiopharmaceuticals and Therapies

Chapter 12: Patent Analysis

  • U.S. Patent Analysis
  • European Patent Analysis
  • Japanese Patent Analysis

Chapter 13: Competitive Landscape

  • Product Launches
  • Collaborations, Agreements and Partnerships
  • Mergers and Acquisitions

Chapter 14: Company Profiles

  • ACCURAY INC.
  • ACTINIUM PHARMACEUTICALS INC.
  • ADVANCED ACCELERATOR APPLICATIONS SA (NOVARTIS CO.)
  • ADVANCED MEDICAL ISOTOPE CORP. (NOW VIVOS INC.)
  • ALLIANCE MEDICAL GROUP
  • AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
  • AYTU BIOSCIENCE INC.
  • BAYER PHARMA AG
  • BLUE EARTH DIAGNOSTICS LTD.
  • BOARD OF RADIATION AND ISOTOPE TECHNOLOGY
  • BRACCO DIAGNOSTIC INC.
  • BTG INTERNATIONAL LTD.
  • C. R. BARD INC. (BECTON DICKINSON)
  • CARDINAL HEALTH INC.
  • CLARITY PHARMACEUTICALS
  • COQUI RADIOPHARMACEUTICALS CORP.
  • ECKERT & ZIEGLER BEBIG
  • ELEKTA
  • ELI LILLY AND CO.
  • FUJIFILM RI PHARMA CO. LTD.
  • GE HEALTHCARE
  • IBA MOLECULAR (NOW CURIUM)
  • ISORAY MEDICAL INC.
  • ISO-TEX DIAGNOSTICS INC.
  • JUBILANT DRAXIMAGE INC.
  • LANTHEUS MEDICAL IMAGING INC.
  • NANOTHEA
  • NATIONAL CENTRE FOR NUCLEAR RESEARCH POLATOM
  • NATIONAL INSTITUTE FOR RADIOELEMENTS (IRE)
  • NAVIDEA BIOPHARMACEUTICALS INC.
  • NORDION INC.
  • NTP RADIOISOTOPES SOC LTD.
  • PHARMALUCENCE INC.
  • PMB ALCEN
  • SIEMENS HEALTHCARE GMBH (NOW SIEMENS HEALTHINEERS)
  • SPECTRUM PHARMACEUTICALS INC.
  • TRIAD ISOTOPES INC.
  • VARIAN MEDICAL SYSTEMS
  • ZEVACOR MOLECULAR
Back to Top